Minnesota Medical Technologies Raises $20.6M in Series A Funding to Commercialize Continence Care Device

Minnesota Medical Technologies is solving a problem most people are too polite to talk about at dinner, and just raised $20.6M in Series A funding to prove that quiet challenges can create very loud opportunities. The round was co-led by HM Venture Partners and Southeast Minnesota Capital Partners, backing a Stewartville, Minnesota team that has spent years focused on a simple idea. Dignity is not a luxury product. It should be engineered.

Congratulations to CEO and President David A. Jonas and to founders Anthony J. Conway, Philip J. Conway, Sarah L. Grinde, and Lonnie M. Boe. This crew knows the terrain. The Conway brothers helped build Rochester Medical into a global continence care business before selling it in 2013. Experience like that does not disappear. It compounds. When a team that has already climbed the mountain laces up the boots again, investors tend to notice.

The company’s flagship device, StaySure, lives right in the middle of a market that affects millions yet rarely gets innovation headlines. Fecal incontinence and accidental bowel leakage are widespread, but most solutions historically revolve around managing accidents instead of preventing them. StaySure takes the opposite approach. The disposable insert is made of medical grade silicone and filled with encased fluid so it gently conforms to the body and helps create a seal designed to stop leaks before they start. Less cleanup. Less anxiety. A lot more freedom to live normally.

That concept cleared a major regulatory gate in July 2025 when the FDA granted 510(k) clearance for StaySure. The device has also been available in Europe since 2021 through Wellspect Healthcare under the name Navina Insert. Add in clinical trial work with Mayo Clinic and a purpose built manufacturing operation in Stewartville and the playbook becomes clear. Build real evidence. Build real manufacturing. Then raise capital to scale.

That is where the new $20.6M comes into play. The funding will fuel U.S. commercialization, expand the sales, marketing, and customer care teams, and build distribution infrastructure that can put StaySure into hospitals, long term care settings, and homes across the country. Southeast Minnesota Capital Partners brings regional conviction. HM Venture Partners brings venture firepower. Together they are betting that solving uncomfortable problems can unlock very comfortable markets.

Medtech history shows that the biggest wins often come from products people do not talk about on stage at conferences but absolutely talk about with their doctors. Minnesota Medical Technologies just stepped into that lane with fresh capital, FDA clearance, and a product whose name promises exactly what patients want. Stay sure. Stay confident. Stay in the game a little longer.